Brief: Geneuro: Preclinical Models Confirm Involvement Of pHERV-W-Env In Human Type 1 Diabetes Pathogenesis

Geneuro SA

25/06/2018 18:02

June 25 (Reuters) - GENEURO SA  GNRO.PA :
    * PRECLINICAL MODELS CONFIRM INVOLVEMENT OF PHERV-W-ENV IN
HUMAN
TYPE 1 DIABETES (T1D) PATHOGENESIS
    * 6--MONTHS RESULTS FROM PHASE IIA TRIAL WITH GNBAC1 IN T1D
EXPECTED BY END OF SEPTEMBER 2018
    * GENEURO IS CONDUCTING A 60-PATIENT PHASE IIA IN T1D,
CALLED
RAINBOW, WITH ITS LEAD PRODUCT, GNBAC1
    * INITIAL 6-MONTHS RESULTS ARE EXPECTED TO BE ANNOUNCED BY
END OF
SEPTEMBER 2018

Source text for Eikon:  ID:nBw6zQSgKa 
Further company coverage:  GNRO.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))